Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 6
2004 5
2005 2
2006 6
2007 2
2008 4
2009 5
2010 3
2011 2
2012 5
2013 1
2014 5
2015 3
2016 3
2017 2
2018 2
2019 3
2020 7
2021 8
2022 2
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Bioactive Compounds for Skin Health: A Review.
Michalak M, Pierzak M, Kręcisz B, Suliga E. Michalak M, et al. Among authors: krecisz b. Nutrients. 2021 Jan 12;13(1):203. doi: 10.3390/nu13010203. Nutrients. 2021. PMID: 33445474 Free PMC article. Review.
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators. Bieber T, et al. N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380. N Engl J Med. 2021. PMID: 33761207 Clinical Trial.
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere).
Simpson EL, Gooderham M, Wollenberg A, Weidinger S, Armstrong A, Soung J, Ferrucci S, Lima RG, Witte MM, Xu W, ElMaraghy H, Natalie CR, Pierce E, Blauvelt A; ADhere Investigators. Simpson EL, et al. JAMA Dermatol. 2023 Feb 1;159(2):182-191. doi: 10.1001/jamadermatol.2022.5534. JAMA Dermatol. 2023. PMID: 36630140 Free PMC article. Clinical Trial.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
[Wet work].
Kieć-Swierczyńska M, Chomiczewska D, Krecisz B. Kieć-Swierczyńska M, et al. Among authors: krecisz b. Med Pr. 2010;61(1):65-77. Med Pr. 2010. PMID: 20437890 Review. Polish.
Risankizumab Therapy for Moderate-to-Severe Psoriasis-A Multi-Center, Long-Term, Real-Life Study from Poland.
Adamczyk M, Bartosińska J, Raczkiewicz D, Adamska K, Adamski Z, Czubek M, Kręcisz B, Kłujszo E, Lesiak A, Narbutt J, Noweta M, Owczarczyk-Saczonek A, Owczarek W, Reich A, Samotij D, Siekierko A, Szczęch J, Walecka I, Ciechanowicz P, Woźniacka A, Liszewska A, Krasowska D. Adamczyk M, et al. Among authors: krecisz b. J Clin Med. 2023 Feb 20;12(4):1675. doi: 10.3390/jcm12041675. J Clin Med. 2023. PMID: 36836209 Free PMC article.
Bacterial Motility and Its Role in Skin and Wound Infections.
Zegadło K, Gieroń M, Żarnowiec P, Durlik-Popińska K, Kręcisz B, Kaca W, Czerwonka G. Zegadło K, et al. Among authors: krecisz b. Int J Mol Sci. 2023 Jan 15;24(2):1707. doi: 10.3390/ijms24021707. Int J Mol Sci. 2023. PMID: 36675220 Free PMC article. Review.
77 results